Candace Graff
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Cytokine Signaling Pathways and Interactions
Papers in
- Oncology 6
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Gary M. Pollack (7 shared papers)Claude Dagenais (1 shared paper)Annette Schwartz (2 shared papers)Lisa Olson (3 shared papers)Robert J. Padley (1 shared paper)Michael Friedman (1 shared paper)Julie Parmentier (1 shared paper)J W Voss (1 shared paper)
- Journals
- Pharmaceutical Research (4 papers)Clinical & Experimental Immunology (2 papers)The Journal of Immunology (1 paper)Biochemical Pharmacology (1 paper)Annals of the Rheumatic Diseases (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Candace Graff
15 papers receiving 1.0k citations
Candace Graff's Hit Papers
Peers
Comparison fields: 5 of 89
- Pharmaceutical Science 228
- Oncology 334
- Pediatrics, Perinatology and Child Health 170
- Rheumatology 121
- Sensory Systems 40
Countries citing papers authored by Candace Graff
This map shows the geographic impact of Candace Graff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candace Graff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candace Graff more than expected).
Fields of papers citing papers by Candace Graff
This network shows the impact of papers produced by Candace Graff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candace Graff. The network helps show where Candace Graff may publish in the future.
Co-authors
The 25 scholars most cited alongside Candace Graff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494) Hit paper breakdown → | 2018 | 286 |
| 2 | 2005 | 218 | |
| 3 | 2003 | 195 | |
| 4 | 2004 | 126 | |
| 5 | 2005 | 74 | |
| 6 | 2003 | 70 | |
| 7 | 2005 | 32 | |
| 8 | 2004 | 19 | |
| 9 | 2008 | 17 | |
| 10 | 2015 | 13 | |
| 11 | 2018 | 10 | |
| 12 | 2015 | 3 | |
| 13 | 2015 | 2 | |
| 14 | HSAbodies: A new class of engineered antibody-based molecules for targeting cancer | 2004 | 1 |
| 15 | [Behavior of vegetative and biochemical parameters in essential hypertension during psychologic stress]. | 1971 | 1 |
About Candace Graff
Candace Graff is a scholar working on Oncology, Immunology, Pediatrics, Perinatology and Child Health, Genetics and Rheumatology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Inflammatory Bowel Disease (2 papers), Systemic Lupus Erythematosus Research (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Viral Infectious Diseases and Gene Expression in Insects (1 paper). The work is most often cited by research in Pharmaceutical Science (228 citations), Oncology (334 citations), Pediatrics, Perinatology and Child Health (170 citations), Rheumatology (121 citations) and Sensory Systems (40 citations). Candace Graff has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Gary M. Pollack, Claude Dagenais, Annette Schwartz, Lisa Olson, Robert J. Padley, Michael Friedman, Julie Parmentier, J W Voss, M.A. Argiriadi and Heidi S. Camp. Their work appears in journals such as Pharmaceutical Research, Clinical & Experimental Immunology, The Journal of Immunology, Biochemical Pharmacology and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.